◀ Back to CDH1

CDH1 — LCN2

Text-mined interactions from Literome

Venkatesha et al., Mol Cancer Res 2006 (Neovascularization, Pathologic) : Previously, we reported that lipocalin 2 could revert 4T1-ras transformed mesenchymal tumor cells to a more epithelial phenotype, increase E-cadherin expression, and suppress cell invasiveness in vitro and in vivo, indicating that lipocalin 2 is a metastasis suppressor
Xu et al., World J Surg 2013 : Overexpression of lipocalin-2 correlated with a lower extent of EMT ( p < 0.05 ), increased E-cadherin expression ( p < 0.05 ), decreased vimentin expression ( p < 0.05 ), and reduced cancer cell migration and invasion in pancreatic cancer